Dengue Virus (DENV) Neutralizing Antibody Kinetics in Children After Symptomatic Primary and Postprimary DENV Infection.

导出 OA

翻译打印收藏纠错

作者： Hannah E,Clapham ^[1] ; Isabel,Rodriguez-Barraquer ^[1] ; Andrew S,Azman ^[1] ; Benjamin M,Althouse ^[2] ; Henrik,Salje ^[1] ; Robert V,Gibbons ^[3] ; Alan L,Rothman ^[4] ; Richard G,Jarman ^[5] ; Ananda,Nisalak ^[5] ; Butsaya,Thaisomboonsuk ^[5] ; Siripen,Kalayanarooj ^[6] ; Suchitra,Nimmannitya ^[6] ; David W,Vaughn ^[5] ; Sharone,Green ^[7] ; In-Kyu,Yoon ^[8] ; Derek A T,Cummings ^[9]

作者单位： Department of Epidemiology, Johns Hopkins School of Public Health, Baltimore, Maryland. ^[1] Institute for Disease Modeling, Bellevue, Washington Santa Fe Institute, Las Cruces, New Mexico New Mexico State University, Las Cruces, New Mexico. ^[2] US Army Institute of Surgical Research, San Antonio, Texas. ^[3] University of Rhode Island, Providence. ^[4] Department of Virology, Armed Forces Research Institute of Medical Science. ^[5] Queen Sirikit National Institute of Child Health, Bangkok, Thailand. ^[6] Division of Infectious Diseases and Immunology, University of Massachusetts Medical School, Worcester. ^[7] Dengue Vaccine Initiative, International Vaccine Institute, Seoul, Korea. ^[8] Department of Epidemiology, Johns Hopkins School of Public Health, Baltimore, Maryland Department of Biology, University of Florida, Gainesville Emerging Pathogens Institute, University of Florida, Gainesville. ^[9]

关键词 dengue longitudinal antibody kinetics neutralizing antibody vaccine